DM Treatment to Evaluate the Efficacy and Safety of Dapagliflozin or Pioglitazone in Patients with Type 2 Diabetes

NCT06875193 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

196

Enrollment

INDUSTRY

Sponsor class

Conditions

Type2diabetes

Interventions

DRUG: DW6012(Dasidiem tab. 10/100mg)

Sponsor

Dong Wha Pharmaceutical Co. Ltd.